Hydrocodone Bitartrate and Homatropine Methlybromide tablets, USP, 5 mg/ 1.5 mg, 30-count bottle, Rx only, Mfd. By:KVK-Tech, Inc., Newtown, PA, 18940 NDC 10702-055-03
Published May 26, 2021 · Recall initiated: April 27, 2021
Summary
FDA records drug Class III recall D-0386-2021, published May 26, 2021 and initiated April 27, 2021. Recalling firm: KVK-Tech, Inc.; Status: Terminated; Reported quantity: 17,096 bottles; Lot: Lot: 15684A, Exp 7/2021. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
- Manufacturer
- KVK-Tech, Inc.
- Distributor
- Distributed Nationwide in the USA
- Lot
- Lot: 15684A, Exp 7/2021
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPreferred Pharmaceuticals Inc., Metformin HCl, Extended Release Tab. USP 500 mg, Generic for Glucophage XR, RxMay 26, 2021
- FDADry Eye Test, Fluorescein Sodium, Ophthalmic Strips USP (0.12mg Fluorescein Sodium), 100 Sterile Strips (50May 26, 2021
- FDASterile Water for Inj., USP, 25 x 100 mL Single Dose Vials per carton, Rx only, For Drug Diluent Use Only,May 26, 2021
- FDAThumbs Up 7 Blue 69K, 10 capsules, Distributed by Ummzy LLC., Made in USA, UPC 617135894673. Packaged inMay 26, 2021
- FDATriple SupremeZen Plus 3500, packaged in cardboard blisters containing one capsule per card, Distributed byMay 26, 2021
- FDALupin Hydrocodone Bitartrate and Homatropine Methylbromide Tablets, USP 5/1.5 mg Rx Only 30 TabletsMarch 21, 2018
Questions about this recall
Was Hydrocodone Bitartrate and Homatropine Methlybromide tablets, USP, 5 mg/ 1.5 mg, 30-count bottle, Rx only, Mfd. By:KVK-Tech, Inc., Newtown, PA, 18940 NDC 10702-055-03 recalled?
Yes. FDA published recall D-0386-2021 on May 26, 2021. Reported hazard: Failed Impurities/Degradation Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE.